Interval between planning and frameless stereotactic radiotherapy for brain metastases: are our margins still accurate?
SAUT, Olivier
Institut de Mathématiques de Bordeaux [IMB]
Centre National de la Recherche Scientifique [CNRS]
Modélisation Mathématique pour l'Oncologie [MONC]
Institut de Mathématiques de Bordeaux [IMB]
Centre National de la Recherche Scientifique [CNRS]
Modélisation Mathématique pour l'Oncologie [MONC]
VENDRELY, Véronique
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Biothérapies des maladies génétiques et cancers
< Réduire
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Biothérapies des maladies génétiques et cancers
Langue
en
Article de revue
Ce document a été publié dans
Neuro-Oncology Practice. 2019-10-01
Oxford University Press
Résumé en anglais
AbstractBackgroundAdvances in intracranial stereotactic radiosurgery (SRS) have led to dramatically reduced planning target volume (PTV) margins. However, tumor growth between planning and treatment may lead to treatment ...Lire la suite >
AbstractBackgroundAdvances in intracranial stereotactic radiosurgery (SRS) have led to dramatically reduced planning target volume (PTV) margins. However, tumor growth between planning and treatment may lead to treatment failure. Our purpose was to assess the kinetics of tumor growth before SRS for brain metastases.MethodsThis retrospective, monocentric study included all consecutive patients (pts) treated for brain metastases secondary to melanoma (ML) and non-small cell lung cancer (NSCLC) between June 2015 and May 2016. All pts underwent diagnostic brain imaging and a radiosurgery planning MRI, during which gross tumor volume (GTV) was delineated. Linear and exponential models were used to extrapolate a theoretical GTV at first day of treatment, and theoretical time to outgrow the PTV margins.ResultsTwenty-three ML and 31 NSCLC brain metastases (42 pts, 84 brain imaging scans) were analyzed. Comparison of GTV at diagnosis and planning showed increased tumor volume for 20 ML pts (96%) and 22 NSCLC pts (71%). The shortest time to outgrow a 1 mm margin was 6 days and 3 days for ML and 14 and 8 days for NSCLC with linear and exponential models, respectively.ConclusionsPhysicians should bear in mind the interval between SRS planning and treatment. A mathematical model could screen rapidly progressing tumors.< Réduire
Mots clés en anglais
Brain metastases
Stereotactic radiotherapy
Margins
Interval
Origine
Importé de halUnités de recherche